?

        當前位置:對照品 > 實驗試劑 > 生化試劑 >
        PFI-1, ≥99%
        ??【編號】:125691

        ??【產品名稱】:PFI-1, ≥99%

        ??【規格】:10MG

        ??【用途】:

          PFI-1, ≥99%

          Product Name: PFI-1
          CAS號:1403764-72-6
          分子式:C16H17N3O4S
          分子量:347.39
          介紹: PFI-1
          貯存: 儲存溫度-20°C
          可溶性: 25°C: DMSO 69 mg/mL; Water <1 mg/mL; Ethanol <1 mg/mL
          生化和生理學機理:
          Description:
          IC50 Value: 1.89nM (EC50 for the inhibition of IL6 production from human blood mononuclear cells stimulated by LPS)
          PFI-1 can efficiently block the interaction of BET BRDs with H3 and H4 acetylated histone tails. Inhibition of the BET-histone interaction results in transcriptional downregulation of a number of oncogenes, providing a novel pharmacologic strategy for the treatment of cancer.
          in vitro: Exposure of sensitive cell lines with PFI-1 results in G1 cell-cycle arrest, downregulation of MYC expression, as well as induction of apoptosis and induces differentiation of primary leukemic blasts. Intriguingly, cells exposed to PFI-1 showed significant downregulation of Aurora B kinase, thus attenuating phosphorylation of the Aurora substrate H3S10 [1], The compound showed <50% inhibition against a panel of 15 targets made up of GPCRs, ion channels, and enzymes at 10 μM at Cerep and <20% inhibition against 50 kinases at 1 μM at Invitrogen. Cell-based activity was tested in an LPS challenge assay in PBMCs. Compound 17 had an EC50 of 1.89 μM (n = 6) for the inhibition of IL6 production from human blood mononuclear cells stimulated by LPS [2].www.atcc360.com
          in vivo: Rodent pharmacokinetics for PFI-1 were studied in both rat (1 mg/kg iv and 2 mg/kg po) and mouse (2 mg/kg sc). After iv administration in the rat, the volume of distribution was 1 L/kg and the plasma clearance was 18/mL·min-1·kg-1, giving a 1 h half-life. The volume of distribution is consistent with the physicochemical properties of the compound, and the clearance is in line with estimates from in vitro rat liver microsome (RLM) data (RLM t1/2 >120 min). After oral dosing in the rat, the oral bioavailability was low at 32% [2].
          Clinical trial: N/A
        上一篇:Poloxime 下一篇:PD153035, ≥98%



          ?
          首 頁 | 對照品| 標準品| 標準物質| 實驗試劑| 培養基| 菌種購買| 新聞中心| 聯系我們| 網站地圖

          2011-2018 北京萊耀生物版權所有豫ICP備17046142號

          ? 主站蜘蛛池模板: 金溪县| 武城县| 晋江市| 饶阳县| 鹰潭市| 宁河县| 湘潭市| 克东县| 江阴市| 宜黄县| 达拉特旗| 高平市| 浦北县| 周宁县| 大竹县| 新源县| 靖西县| 临西县| 通城县| 禹州市| 武安市| 南丰县| 敦化市| 资兴市| 甘南县| 普安县| 贞丰县| 关岭| 罗平县| 乌兰浩特市| 兰西县| 开鲁县| 饶平县| 松桃| 贺兰县| 澄迈县| 白水县| 汾西县| 肥东县| 沽源县| 和林格尔县|